Logo do repositório
 
Miniatura indisponível
Publicação

p53 as the Focus of Gene Therapy: Past, Present and Future

Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
Valente et al_Current Drug Targets_2018.pdf1.46 MBAdobe PDF Ver/Abrir

Orientador(es)

Resumo(s)

Several gene deviations can be responsible for triggering oncogenic processes. However, mutations in tumour suppressor genes are usually more associated to malignant diseases, with p53 being one of the most affected and studied element. p53 is implicated in a number of known cellular functions, including DNA damage repair, cell cycle arrest in G1/S and G2/M and apoptosis, being an interesting target for cancer treatment.

Descrição

Palavras-chave

Antineoplastic Agents Combined Modality Therapy Genetic Therapy Genetic Vectors Humans Mutation Neoplasms Transfection Tumor Suppressor Protein p53

Contexto Educativo

Citação

Projetos de investigação

Unidades organizacionais

Fascículo

Editora

Bentham Science Publishers

Licença CC

Métricas Alternativas